Trademark: 88207811
Word
FILTRICINE
Status
Dead
Status Code
602
Status Date
Tuesday, June 13, 2023
Serial Number
88207811
Mark Type
4000
Filing Date
Tuesday, November 27, 2018
Published for Opposition
Tuesday, September 10, 2019
Abandoned Date
Wednesday, March 8, 2023

Trademark Owner History
Filtricine, Inc. - Owner At Publication

Classifications
42 Research and development of technology in the field of dietary and nutritional supplement; dietary and nutritional supplement research and development; research and development of new in dietary and nutritional supplement products for the purpose of treating cancer; providing medical and scientific research information in the field of dietary and nutritional supplements; medical and scientific research, namely, conducting clinical trials for others; laboratory research services relating to dietary and nutritional supplements; research and development of new dietary and nutritional supplement products for use in the field of dialysis; medical and scientific research in the field of dietary and nutritional supplement in immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology including fertility, infectiology including virology, ophthalmology, hepatology, neurology, and geriatrics; providing medical and scientific research information in the field of dietary and nutritional supplements and clinical trials; dietary and nutritional supplement research, namely, medical and scientific research relating to remediating nutrient deprivation for use in connection with a wide variety of therapeutic areas

Trademark Events
Jun 13, 2023
Abandonment Notice E-Mailed - Failure To Respond
Jun 13, 2023
Abandonment Notice Mailed - Failure To Respond
Jun 13, 2023
Abandonment - Failure To Respond Or Late Response
Dec 7, 2022
Notification Of Non-Final Action E-Mailed
Dec 7, 2022
Non-Final Action E-Mailed
Dec 7, 2022
Su - Non-Final Action - Written
Nov 9, 2022
Statement Of Use Processing Complete
Nov 4, 2022
Use Amendment Filed
Nov 4, 2022
Teas Statement Of Use Received
Apr 26, 2022
Notice Of Approval Of Extension Request E-Mailed
Apr 25, 2022
Sou Extension 5 Granted
Apr 20, 2022
Sou Extension 5 Filed
Apr 25, 2022
Case Assigned To Intent To Use Paralegal
Apr 20, 2022
Sou Teas Extension Received
Apr 12, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 12, 2022
Teas Change Of Correspondence Received
Apr 12, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 12, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 12, 2022
Teas Change Of Owner Address Received
Oct 19, 2021
Notice Of Approval Of Extension Request E-Mailed
Oct 15, 2021
Sou Extension 4 Granted
Oct 15, 2021
Sou Extension 4 Filed
Oct 15, 2021
Sou Teas Extension Received
Apr 27, 2021
Notice Of Approval Of Extension Request E-Mailed
Apr 23, 2021
Sou Extension 3 Granted
Apr 23, 2021
Sou Extension 3 Filed
Apr 23, 2021
Sou Teas Extension Received
Oct 16, 2020
Notice Of Approval Of Extension Request E-Mailed
Oct 14, 2020
Sou Extension 2 Granted
Oct 14, 2020
Sou Extension 2 Filed
Oct 14, 2020
Sou Teas Extension Received
May 6, 2020
Notice Of Approval Of Extension Request E-Mailed
May 4, 2020
Sou Extension 1 Granted
May 4, 2020
Sou Extension 1 Filed
May 4, 2020
Sou Teas Extension Received
Nov 5, 2019
Noa E-Mailed - Sou Required From Applicant
Sep 10, 2019
Official Gazette Publication Confirmation E-Mailed
Sep 10, 2019
Published For Opposition
Aug 21, 2019
Notification Of Notice Of Publication E-Mailed
Aug 8, 2019
Approved For Pub - Principal Register
Aug 6, 2019
Examiner's Amendment Entered
Aug 6, 2019
Assigned To Lie
Aug 6, 2019
Notification Of Examiners Amendment E-Mailed
Aug 6, 2019
Examiners Amendment E-Mailed
Aug 6, 2019
Examiners Amendment -Written
Feb 14, 2019
Notification Of Non-Final Action E-Mailed
Feb 14, 2019
Non-Final Action E-Mailed
Feb 14, 2019
Non-Final Action Written
Feb 14, 2019
Assigned To Examiner
Dec 15, 2018
New Application Office Supplied Data Entered
Nov 30, 2018
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24